Lv3
334 积分 2024-02-24 加入
Tubulin polymerization inhibitors in early clinical studies as cancer therapeutics
2小时前
待确认
Recent Advances in Combretastatin A-4 Inspired Inhibitors of TubulinPolymerization: An Update
5小时前
已完结
Medicinal Chemistry of Combretastatin A4: Present and Future Directions
12天前
已完结
Cytotoxic, Antioxidant, and Anti-Genotoxic Properties of Combretastatin A4 in Human Peripheral Blood Mononuclear Cells: A Comprehensive In Vitro Study
12天前
已完结
Combretastatin A4 nanodrug combined plerixafor for inhibiting tumor growth and metastasis simultaneously
13天前
已完结
Combretastatin A4 Nanodrug‐Induced MMP9 Amplification Boosts Tumor‐Selective Release of Doxorubicin Prodrug
13天前
已完结
Combretastatin A4 phosphate
14天前
已完结
Combretastatin A4-combined photodynamic therapy for enhanced tumor therapeutic efficacy
18天前
已完结
Site-Specific and Far-Red-Light-Activatable Prodrug of Combretastatin A-4 Using Photo-Unclick Chemistry
18天前
已完结
N-Benzyl arylamide derivatives as novel and potent tubulin polymerization inhibitors against gastric cancers: Design, structure–activity relationships and biological evaluations
1个月前
已完结
皖公网安备34019202002308
